Scope (new version):

Scope (old version):

JPM particularly encourages submissions that focus on the following topics within its scope:

Topics of interest with a view towards personalized medicine include (but are not limited to) the following:

• Novel and emerging informatics applied to personalized medicine, including well-grounded artificial intelligence/machine learning-enabled methods;
• Diagnostic characteristics for disease subtypes, or evidence for groups of patients who are likely to respond to therapy vs. those who do not;
• Processes such as organ/tissue transplantation, where de-personalizing donor tissue results in broader positive outcomes for recipients.

Papers that may be considered out of scope include the following:

• Method papers that do not describe subpopulations where their approaches might be most or least effective;
• Reports and theoretical studies with broad implications only

• Omics-based studies of disease risk, disease prognosis, and response to therapy;
• Biomarker identification and application;
• Drug target discovery and integration with individualized therapy;
• Pharmacogenomics—the genetics and biochemistry of drug uptake, action, and metabolism;
• Prediction-based drug safety;
• Novel therapeutics: genetic-based, nanotechnology, targeting strategies;
• Advancements in Technologies and Resources, including the following:
  • Genetic testing, sequencing technologies, and molecular diagnostics;
  • Expression analysis, metabolomics, proteomics
  • Microbiomes;
  • Genome-wide association studies;
  • Bioinformatics and health informatics;
  • Biostatistics.
• Personalization of omics-based non-drug-related health interventions;
• Regulation and bioethics in personalized medicine.